PCSK9 inhibitors and statin intolerance, pembrolizumab for melanoma, CDC opioid prescribing guideline, and more | Learning | The JAMA Network
[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
Purchase Options:
[Skip to Content Landing]
Sign in or Create an Account to track your personal CME/MOC activities
0 Credit Audio 8 min 51 sec JAMA April 19, 2016

PCSK9 inhibitors and statin intolerance, pembrolizumab for melanoma, CDC opioid prescribing guideline, and more

×